Breaking News
First Coronavirus Vaccine to Be Tested in U.S. Boosts Participants’ Immune Systems
The first coronavirus vaccine to be tested in the U.S. has boosted the immune systems of the study's participants.
“No matter how you slice this, this is good news,” Dr. Anthony Fauci said to The Associated Press.
The vaccine has been developed by researchers at the National Institutes of Health and Moderna Inc. It will soon be tested in a study of 30,000 people. The test begins on July 27th.
Fox News reported that this is the biggest COVID-19 study of its kind so far.
“Researchers reported the good news from their original data, which was taken from 45 volunteers who rolled up their sleeves in March, to serve as the initial test subjects,” said the Fox News report.
https://twitter.com/GreenBayWiscon/status/1283333746326827008
The participants developed neutralizing antibodies in their bloodstream – helping to block infection.
“This is an essential building block that is needed to move forward with the trials that could actually determine whether the vaccine does protect against infection,” said Dr. Lisa Jackson of the Kaiser Permanente Washington Research Institute in Seattle.
Results of the 30,000-person study are hoped to arrive by the end of this year.
According to Fox News, the vaccine was given in two doses, each being one month apart. No serious side effects were found, but more than half of the participants complained of flu-like reactions to the shots. These reactions were then seen as common.
Around two dozen possible vaccines are in various stages of development and testing around the world, Fox News also reported.
Up Next:
